Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors : should we treat beyond two years?
Source
Acta oncologica - ISSN 0284-186X-64 (2025) p. 979-988
Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors : multicenter study using natural language processing on Belgian hospital data
Source
ESMO realwWorld data and digital oncology - ISSN 2949-8201-7 (2025) p. 1-9